Event Type: Conference call for group of analysts and investors (earnings call)
Date and Time: Monday, August 03, 2026 at 5:30 PM IST
Purpose: To discuss the Unaudited Standalone Financial Results of the Company for the quarter ended June 30, 2026 (Q1 FY27)
Timing Relative to Earnings: The call is scheduled after the quarter end but the announcement does not specify whether earnings have already been announced
Management Participants: Mr. Shiven Arora - Managing Director, Mr. V.K. Singh - Chief Operating Officer, Mr. Ganesh Karuppannan - Chief Financial Officer, Mr. Sanjay Sinha - Deputy Chief Financial Officer
Access Information: A DiamondPass™ link is provided for immediate access (no wait time). International toll-free numbers include USA: +1-866-746-2133, UK: 08081011573, Singapore: 8001012045, Hong Kong: 800964448. Universal access number: +91 22 7115 8008
Compliance Statement: The document is filed under Regulation 30 read with Schedule III - Part A of SEBI Listing Regulations, 2015, but does not explicitly state whether unpublished price sensitive information (UPSI) will be shared
Additional Notes Section
Financial Data Disclosure: No financial figures or results are disclosed in this announcement
Company Business Description: Blue Jet Healthcare operates as a specialty pharmaceutical and healthcare ingredient and intermediate company under a contract development and manufacturing organization (CDMO) business model. The company has specialized chemistry capabilities in contrast media intermediates and high-intensity sweeteners, supplying to major companies including GE Healthcare, Guerbet, Bracco, Colgate Palmolive (India) Limited, and Unilever
Contact Information: Provided for Ms. Sweta Poddar (Company Secretary & Compliance Officer) and EY Investor Relations representatives Diwakar Pingle and Kunal Bhoite
